XML 23 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows (Unaudited)
$ in Thousands
 6 Months Ended
Jun. 30, 2021
USD ($)
Jun. 30, 2020
USD ($)
Cash Flows From Operating Activities:    
Net loss and comprehensive loss for the period $ (47,726) $ (24,403)
Adjustments to reconcile net loss to net cash used in operating activities:    
Share-based compensation expense 5,240 660
Depreciation expense 734 403
Non-cash lease expense 748 305
Foreign exchange (gain) loss (13) 1,162
Amortization of premiums on marketable securities 54  
Deferred tax (626) (60)
Changes in operating assets and liabilities:    
Prepaid expenses 4,622 (2,577)
Research and development tax credits receivable (627) (381)
Other receivables 556 (725)
Other non-current assets   (535)
Accounts payable 1,155 915
Accrued expenses and other current liabilities 4,509 2,371
Operating lease liability, current portion (272) (9)
Income tax payable 44 133
Operating lease liability, net of current portion (238) (292)
Deferred revenue (445) 50,000
Net cash (used in) provided by operating activities (32,285) 26,967
Cash Flows From Investing Activities:    
Purchases of property and equipment (1,201) (43)
Proceeds from maturities of marketable securities 3,750  
Purchase of marketable securities (3,438)  
Net cash used in investing activities (889) (43)
Cash Flows From Financing Activities:    
Proceeds from exercise of stock options 632 488
Proceeds from issuance of warrant   15,000
Net proceeds from issuance of common shares in initial public offering   233,760
Net cash provided by financing activities 632 249,248
Effect of exchange rate fluctuations on cash held (1) (1,045)
Net (Decrease) Increase In Cash And Cash Equivalents And Restricted Cash (32,543) 275,127
Cash and cash equivalents and restricted cash at beginning of period 326,396 95,005
Cash and cash equivalents and restricted cash at end of period 293,853 370,132
Reconciliation Of Cash And Cash Equivalents And Restricted Cash    
Cash and cash equivalents 293,635 369,933
Restricted cash 218 199
Total cash and cash equivalents and restricted cash 293,853 370,132
Supplemental Disclosure Of Cash Flow Information:    
Property and equipment purchases in incurred but not yet paid 38 423
Right-of-use asset obtained in exchange for new operating lease liability $ 705  
Initial public offering costs in accounts payable   102
Initial public offering costs in accruals and other current liabilities   1,615
Conversion of Series A and B convertible preferred shares into common shares   135,997
Issuance of warrant and conversion into common shares,Value   $ 15,000